Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconSGENSeagen$43.15bnn/an/a
us flag iconRVMDRevolution Medicines$30.97bnn/an/a
us flag iconIQVIqvia Holdings$28.23bn19.44n/a
us flag iconINSMInsmed$23.66bnn/an/a
us flag iconBNTXBioNTech SE$22.99bnn/an/a
us flag iconEXASExact Sciences$20.03bnn/an/a
us flag iconASNDAscendis Pharma A/S$15.44bn28.06n/a
us flag iconRGCRegencell Bioscience Holdings$14.13bnn/an/a
us flag iconSMMTSummit Therapeutics$13.09bnn/an/a
us flag iconKRTXKaruna Therapeutics$12.58bnn/an/a
us flag iconEXELExelixis$12.48bn16.15n/a
us flag iconIONSIonis Pharmaceuticals$12.27bnn/an/a
us flag iconMDGLMadrigal Pharmaceuticals$12.07bnn/an/a
us flag iconMEDPMedpace Holdings$11.86bn26.13n/a
us flag iconARWRArrowhead Pharmaceuticals$10.64bnn/an/a
us flag iconCYTKCytokinetics$10.58bnn/an/a
us flag iconRXDXPrometheus Biosciences$9.56bnn/an/a
us flag iconPRAXPraxis Precision Medicines$9.55bnn/an/a
us flag iconICLRIcon$8.90bn11.48n/a
us flag iconIMGNImmunoGen$8.72bnn/an/a